Alethia Young analyst CANTOR FITZGERALD

Currently out of the existing stock ratings of Alethia Young, 227 are a BUY (80.78%), 54 are a HOLD (19.22%).

Alethia Young

Work Performance Price Targets & Ratings Chart

Analyst Alethia Young works at CANTOR FITZGERALD with a stock forecast success ratio of 52.84% fulfilled within 279.7 days on average. Previously, Alethia Young worked at CREDIT SUISSE, MACQUARIE, DEUTSCHE BANK.

Alethia Young’s has documented 585 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 16-Oct-2023.

Wall Street Analyst Alethia Young

Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for BIIB (BIOGEN) at 11/3/2020. The price target of $278 was fulfilled within 1 day with a profit of $30.99 (12.55%) receiving and performance score of 125.46.

Average potential price target upside

ACHN Achillion Pharmaceuticals ADVM Adverum Biotechnologies AGIO Agios Pharm ALNY Alnylam Pharmaceuticals AMGN Amgen ARNA Arena Pharmaceuticals ARWR Arrowhead Pharmaceuticals ASND Ascendis Pharma AS BIIB Biogen FATE Fate Therapeutics GILD Gilead Sciences ICPT Intercept Pharmaceuticals INCY yte PBYI Puma Biotechnology PTCT PTC Therapeutics RAPT RAPT Therapeutics REGN Regeneron Pharmaceuticals SPPI Spectrum Pharmaceuticals SRPT Sarepta Therapeutics TGTX TG Therapeutics VRTX Vertex Pharmaceuticals BMRN Biomarin Pharmaceutical AA Alcoa Corp AKBA Akebia Ther ALXN Alexion Pharmaceuticals ARVN Arvinas AUPH Aurinia Pharmaceuticals CELG Celgene CLF Cleveland-Cliffs CRIS Curis FCX Freeport-McMoran Copper & Gold GBT Global Blood Therapeutics MYOK MyoKardia PRVB Provention Bio ELDN Eledon Pharmaceuticals UTHR United Therapeutics CLVS Clovis Oncology NKTX Nkarta  NEXI Neximmune MRNS Marinus Pharmaceuticals STML Stemline Therapeutics STOK Stoke Therapeutics THRX Theseus Pharmaceuticals VSTM Verastem LBPH Longboard Pharmaceuticals ALXO Alx Oncology Holdings  RCUS Arcus Biosciences

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$1.82 (1011.11%)

5

4 years 9 months 25 days ago

2/3 (66.67%)

$-0.96 (-32.43%)

528

Hold

4

6 years 20 days ago

4/4 (100%)

$-0.81 (-16.84%)

106

Buy

5

$4.82 (2677.78%)

6

6 years 2 months 17 days ago

0/4 (0%)

$2.14 (74.83%)

Buy

10

6 years 5 months 16 days ago

0/2 (0%)

$5.79 (137.53%)

Hold

4

$3.82 (2122.22%)

5

6 years 5 months 17 days ago

6/7 (85.71%)

$0.17 (4.44%)

49

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Alethia Young is most bullish on?

Potential upside of $25.82 has been obtained for RCUS (ARCUS BIOSCIENCES)

Which stock is Alethia Young is most reserved on?

Potential downside of -$143.35 has been obtained for REGN (REGENERON PHARMACEUTICALS)

What Year was the first public recommendation made by Alethia Young?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?